EnteroTrack, LLC
StreetZero Signal 72
About EnteroTrack, LLC
EnteroTrack, LLC develops the EnteroTracker, a minimally invasive esophageal string test for monitoring eosinophilic esophagitis and other upper GI conditions. The company offers a simple at-home screening option that collects mucosal samples for biomarker analysis as an alternative to repeated endoscopies. It is headquartered in Aurora, CO and was founded in 2013. The technology is supported by partnerships with Children's Hospital Colorado, University of Colorado Denver, and patient advocacy groups.
LATEST FUNDINGPrivate Placement
$2.0M
Announced 2026-09-25
TOTAL RAISED$4.91M
IN THE NEWS
- 🔗 EnteroTrack - Products, Competitors, Financials, Employees, Headquarters Locations
- 🔗 EnteroTrack LLC. - Innovative solution for collecting and sampling upper GI tract mucosa
- 🔗 Growing Advanced Industries in Colorado: OEDIT Announces Grants to 32 Colorado Startups and Researchers, Boosting Advanced Industries | Colorado Office of Economic Development and International Trade
- 🔗 EnteroTracker® Technology | EnteroTrack
- 🔗 EnteroTrack – Minimally Invasive Sampling for EoE Monitoring
EMPLOYEES2-10
FOUNDED2013
HQAurora, CO, USA
Industry
Biotechnology
Tags
BiotechnologyDiagnosticsMedical Devices
Key highlights
- Raised $2M private placement and $250k Colorado grant for esophageal diagnostics.
- EnteroTracker provides minimally invasive alternative to endoscopy for EoE monitoring.
- Total funding reported at $4.91M with accelerator support from CancerX and CDL programs.
- Technology billed under PLA CPT Code 0095U and partnered with CHCO and UC Bioengineering.
Ask StreetZero about EnteroTrack, LLC
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account